Next Article in Journal
Safe and Effective Cynomolgus Monkey GLP—Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders
Next Article in Special Issue
Solubilization of Paclitaxel with Natural Compound Rubusoside toward Improving Oral Bioavailability in a Rodent Model
Previous Article in Journal
Swallowability of Minitablets among Children Aged 6–23 Months: An Exploratory, Randomized Crossover Study
Previous Article in Special Issue
Oral Delivery of Nucleic Acids with Passive and Active Targeting to the Intestinal Tissue Using Polymer-Based Nanocarriers
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(1), 197; https://doi.org/10.3390/pharmaceutics14010197
Action Date Notes Link
article xml file uploaded 15 January 2022 10:09 CET Original file -
article xml uploaded. 15 January 2022 10:09 CET Update https://www.mdpi.com/1999-4923/14/1/197/xml
article pdf uploaded. 15 January 2022 10:09 CET Version of Record https://www.mdpi.com/1999-4923/14/1/197/pdf
article html file updated 15 January 2022 10:11 CET Original file -
article html file updated 31 July 2022 04:00 CEST Update https://www.mdpi.com/1999-4923/14/1/197/html
Back to TopTop